T7 RNA Polymerase ELISA kit _ 36705ES

Save $410.00
YeasenSKU: 36705ES48

Size: 48 T
Price:
Sale price$395.00 Regular price$805.00

Shipping calculated at checkout

Stock:
In stock

Description

T7 RNA polymerase uses double-stranded DNA containing the T7 promoter sequence (5’-TAATACGACTCACTATAG*-3’) as a template and NTPs as substrates to synthesize RNA complementary to the reverse strand of DNA downstream of the promoter. Both linear double-stranded DNA with blunt ends or 5’ overhangs can serve as template substrates for T7 RNA polymerase, meaning linearized plasmids or PCR products can be used as templates for in vitro RNA synthesis.  

This kit employs a sandwich enzyme-linked immunosorbent assay (ELISA) principle to detect residual T7 RNA polymerase. T7 RNA polymerase standards and test samples are added to microplate wells pre-coated with anti-T7 RNA polymerase antibodies (36705-A). Diluted biotin-labeled T7 RNA polymerase detection antibodies (36705-C) are then added, followed by Streptavidin-HRP (SA-HRP) (36705-D), forming an antibody + antigen + antibody-biotin + SA-HRP complex. After washing, TMB substrate (36705-H) is added for color development. TMB is catalyzed by HRP to transition from colorless to blue and finally to yellow upon addition of stop solution (36705-I). The intensity of the yellow color is positively correlated with the amount of T7 RNA polymerase detected in the sample.

Features

High Sensitivity: Quantitative lower limit (LOQ) of 1 ng/mL; detection limit (LOD) as low as 0.318 ng/mL.

High Precision: Intra-assay CV <10%; intermediate precision (inter-assay CV) <15%.

High Accuracy: Spike recovery rates consistently within 70–130%.

Strong Specificity: No significant variation observed in T7 RNA polymerase values after adding various interfering substances.

Excellent Stability: Stable for 7 days at 37 °C without performance loss.

Regulatory Compliance: Fully validated in accordance with ChP, USP, and ICH Q2 (R2) guidelines.

Quality Assurance: All critical raw materials, including coated and detection antibodies and standards, are independently developed and fully traceable.

Audit-Ready: Stable manufacturing process with controlled lot-to-lot variation and comprehensive audit documentation.

Specifications

Parameter

Specification

Detection Range

1 – 32 ng/mL

Assay Method

Double-antibody sandwich

Assay Time

3.5 hours

Sensitivity

0.318 ng/mL

Dilution Linearity

Difference <20% compared with undiluted samples

Recovery Rate

70% – 130%

Intra-assay Variation

<10%

Inter-assay Variation

<15%

Components

Components No.

Name

36705S48

(48 T)

36705ES96

(96 T)

36705-A

Anti-T7 RNA Polymerase coated microtiter strips

48 T

96 T

36705-B*

Standard: T7 RNA Polymerase

1 vial

2 vial

36705-C

Detection AntibodyBiotin-conjugated Antibodies

60 μL

120 μL

36705-D

Streptavidin-HRP

30 μL

60 μL

36705-E

Dilution Buffer 1

25 mL

45 mL

36705-F

Wash Buffer Concentrate (20×)

25 mL

50 mL

36705-G

Dilution Buffer 2

15 mL

30 mL

36705-H

TMB Substrate

8 mL

15 mL

36705-I

Stop Solution

5 mL

10 mL

36705-J

Plate Sealer

3 each

5 each

Storage

Store at 2-8°C. The shelf life is 1 year when unopened, and 6 months after opening.

Upon receipt of the product, please check if all components are complete, and immediately store them at the corresponding storage temperature.

Figures

1. Good Linearity

Table 1. Linearity Range: 1~32 ng/mL,R2=0.999 ,CV≤5%。

Std

Concn.(ng/mL)

AVG(ng/mL)

Recovery(%)

CV%

Std 1

32

31.965

99.9%

2.2%

Std 2

16

16.070

100.5%

5.0%

Std 3

8

7.812

97.7%

2.1%

Std 4

4

4.192

104.8%

0.8%

Std 5

2

2.020

101.8%

3.5%

Std 6

1

1.173

117.3%

0.0%

NC

0

/

/

/

Figure 1. Standard curve ) for .T7 RNA Polymerase ELISA kit

Figure 1. Standard curve ) for .T7 RNA Polymerase ELISA kit

2. High Specificity

Figure 2. Cross-reactivity comparison.

Figure 2. Cross-reactivity comparison.

Eight process-related proteins were tested using the Cat#36705ES kit to evaluate potential cross-reactivity of the T7 RNA Polymerase antibody with nine different proteins. Positive control (PC, 1 ng/mL) and negative control (NC, 0 ng/mL) were included. Results showed that the eight process-related proteins (10 µg/mL) produced signals comparable to the negative control, with detected concentrations below the kit’s quantitation limit (1 ng/mL), indicating no cross-reactivity.

Table 2. Cross-reactivity Data with Proteins Added in Eight Manufacturing Processes

Protein Types

OD Value

Concentration(ng/mL

PC-1 ng/mL

0.165

1

NC-0 ng/mL

0.123

0

UltraNuclease

0.125

n.d.

Salt Active UltraNuclease

0.137

n.d.

DNase I

0.161

n.d.

Murine RNase Inhibitor

0.151

n.d.

Vaccinia Capping Enzyme

0.128

n.d.

Inorganic Pyrophosphatase

0.127

n.d.

mRNA Cap 2´-O-Methyltransferase

0.125

n.d.

1%BSA

0.131

n.d.

 3.High Accuracy: Spike recovery rates consistently within 70–130%.

Table 3. Dilution Linearity and Spike Recovery

Sample Dilution

Measured Value (ng/mL)

Linearity (%)

Sample + Spike

Measured Value (ng/mL)

Recovery (%)

S + Std1

31.467

/

S + Std1

31.467

97.0%

13.729

87.3%

S + Std3

7.625

90.2%

6.015

87.6%

S + Std5

2.248

91.6%

3.068

102.0%

S (Sample)

0.907

/

16×

1.742

113.6%

/

/

/

 Equal volumes of high, medium, and low concentrations of T7 standards were spiked into mRNA purification samples, with the high-level spiked sample further subjected to serial dilutions. T7 detection results from diluted samples, spiked samples, and unspiked controls all showed linearity and spike recovery rates within 80%–120%.

Spike Recovery Rate = Measured Value / (50% Spiked Standard + 50% Sample Value)

4. High Sensitivity: Quantitative lower limit (LOQ) of 1 ng/mL; detection limit (LOD) as low as 0.318 ng/mL.

Table 4. LOQ

Std6 theoretical value(ng/mL)

Std 6 test mean value(ng/mL)

Test repetitions

CV%

Recovery

1

0.858

24

12.6%

85.8%

The limit of quantification for this product is determined by diluting the lowest concentration point of the standard curve, where the coefficient of variation (CV) at the lowest concentration is less than 20%. This is defined as the limit of quantification, which is 1 ng/mL.

Table 4. LOD

Mean value(OD)

SD(OD)

Mean value +2SD (OD)

Mean value +2SD(ng/mL)

0.0527

0.0038

0.0604

0.3176

The detection limit of this product is defined as the standard concentration corresponding to the mean detection value of the negative control (NC) plus two times the standard deviation. By measuring 24 NC standards, calculating the mean and standard deviation, the detection limit is determined to be 0.318 ng/mL.

Documents:

Safety Data Sheet

36705_MSDS_HB250925.PDF

Manuals

36705_Manual_Ver.EN20250925

Payment & Security

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Inquiry

You may also like

FAQ

The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.

Certain applications may require additional third-party intellectual property rights.

Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.